FEDERAL STREET STRATEGIES, LLC

Lobbying for ABBVIE, INC. · Biopharmaceutical Research & Development Company.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Apr 21, 2025

Lobbying activity 2

Health Issues

Patient Access to drug treatment therapies; and drug cost and drug pricing reform. Oversight of the pharmaceutical industry and drug pricing. Monitoring policies as they relate to PBMs

Medicare/Medicaid

Medicare Part D policies. Monitoring Policies related to the 340b program. Issues related to the implementation of the Inflation Reduction Act

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.